博士（医学）, 信州大学

外科学一般、小児外科学, 内分泌・甲状腺・副甲状腺・乳腺外科

Fluctuations in Gut MicrobiomeComposition During Immune Checkpoint Inhibitor Therapy.
Sarkar J, Cortes Gomez E, Oba T, Chen H, Dy GK, Segal BH, Ernstoff MS, Ito F.
World J Oncol., 2023年

Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell LungCancer Patients Treated with Chemo-Immunotherapy.
Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal B, DyGK, Ito F.
Cancer Res Commun, 2023年

Changes in thepathophysiology of primary hyperparathyroidism and analysis of postoperative recurrence cases at a regional corehospital in Japan: experience of 35 years in Shinshu University Hospital.
Kanai T, Oba T, Morikawa H, Amitani M, Chino T, Shimizu T, Ono MT, Maeno K, Ito KI, Ito T.
Ann Palliat Med., 2023年

The Advantage of Using an Optical See-Through Head-Mounted Displayin Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study.
Shimizu T, Oba T (co-first author), Ito KI.
J Clin Med, 2023年

Neutrophil-to-lymphocyte ratio is associated with the proportion of poorly differentiated components in papillarythyroid carcinoma.
Oba T, Kazuma M, Kiyosawa N, Morikawa H, Amitani M, Chino T Shimizu T, Ono M, Ito T, Kanai T, Ito KI.
J Surg Res, 2023年

著しい副甲状腺機能亢進を呈しながら術前画像診断が困難であった嚢胞性副甲状腺腺腫の１例
久保田 諭史, 島田 恭輔, 髙山 昇平, 大場 崇旦, 伊藤 研一, 駒津 光久
信州医学雑誌, 70(3), 189-194, 2022年06月

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1(+) CD8(+) T cells
Yamauchi, Takayoshi; Hoki, Toshifumi; Oba, Takaaki; Kajihara, Ryutaro; Attwood, Kristopher; Cao, Xuefang; Ito, Fumito;
CANCER IMMUNOLOGY IMMUNOTHERAPY, 71(1), 137-151, 2022年01月

がん免疫療法におけるT細胞に発現するCX3CR1の重要性
大場 崇旦;オオバ タカアキ;伊藤 史人;イトウ フミト
臨床免疫・アレルギー科 = Clinical immunology & allergology / 臨床免疫・アレルギー科編集委員会 編, 76(5), 573-580, 2021年11月

The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over time
Ono, Mayu; Oba, Takaaki; Shibata, Tomohiro; Ito, Ken-Ichi;
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(11), 3211-3224, 2021年11月

In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models
Oba, Takaaki; Makino, Kenichi; Kajihara, Ryutaro; Yokoi, Toshihiro; Araki, Ryoko; Abe, Masumi; Minderman, Hans; Chang, Alfred E.; Odunsi, Kunle; Ito, Fumito;
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 9(5), e002432, 2021年05月

HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells
Oba T, Ono M, Matoba H, Uehara T, Hasegawa Y, Ito KI.
Breast Cancer Res Treat., 186(1), 37-51, 2021年02月

Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin
Oba, Takaaki; Maeno, Kazuma; Ono, Mayu; Ito, Tokiko; Kanai, Toshiharu; Ito, Ken-ichi;
ANTICANCER RESEARCH, 41(1), 445-452, 2021年01月

Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
9. Watanabe T, Oba T, Tanimoto K, Shibata T, Kamijo S, Ito KI.
PLOS ONE, 2021年

Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature.
11. Shimizu T, Oba T, Chino T, Soma A, Ono M, Ito T, Kanai T, Maeno K, Sato Y, Uehara T, Ito KI.
Thyroid Res, 2021年

Fibroadenoma in a young male breast: A case report and review of the literature.
13. Morikawa H, Nobuoka M, Amitani M, Shimizu T, Ohno K, Ono M, Oba T, Ito T, Kanai T, Maeno K, Uehara T, Ito KI.
Clin Case Rep., 2021年

Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors
Oba, Takaaki; Kajihara, Ryutaro; Yokoi, Toshihiro; Repasky, Elizabeth A.; Ito, Fumito;
CANCER RESEARCH, 81(24), 6183-6195, 2021年

Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression
Patel, Ankit; Oba, Takaaki; Kajihara, Ryutaro; Yokoi, Toshihiro; Abrams, Scott I.; Ito, Fumito;
JOURNAL OF IMMUNOLOGY, 207(5), 1298-1309, 2021年

Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
Yokoi, Toshihiro; Oba, Takaaki; Kajihara, Ryutaro; Abrams, Scott, I; Ito, Fumito;
SCIENTIFIC REPORTS, 11(1), 21992, 2021年

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
Yamauchi, Takayoshi; Hoki, Toshifumi; Oba, Takaaki; Jain, Vaibhav; Chen, Hongbin; Attwood, Kristopher; Battaglia, Sebastiano; George, Saby; Chatta, Gurkamal; Puzanov, Igor; Morrison, Carl; Odunsi, Kunle; Segal, Brahm H.; Dy, Grace K.; Ernstoff, Marc S.; Ito, Fumito;
NATURE COMMUNICATIONS, 12(1), 1402, 2021年

Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer
Oba, Takaaki; Maeno, Kazuma; Amitani, Masatsugu; Shimizu, Tadafumi; Ohno, Koichi; Ono, Mayu; Ito, Tokiko; Kanai, Toshiharu; Uehara, Takeshi; Ito, Ken-Ichi;
Endocrine journal, 68(11), 1329-1336, 2021年

Multicenter retrospective study on the use of Curebest (TM) 95GC Breast for estrogen receptor-positive and node-negative early breast cancer
Tsukamoto, Fumine; Arihiro, Koji; Takahashi, Mina; Ito, Ken-ichi; Ohsumi, Shozo; Takashima, Seiki; Oba, Takaaki; Yoshida, Masayuki; Kishi, Kazuki; Yamagishi, Keisuke; Kinoshita, Takayuki;
BMC CANCER, 21(1), 1077, 2021年